Health Condition 1: E084- Diabetes mellitus due to underlying condition with neurological complications
Conditions
Interventions
Intervention1: AAVARAI KIRUTHAM: 4ml per oral twice in a day just before meals with milk for 3 months
Control Intervention1: not applicable: not applicable
Sponsors
AYOTHIDOSS PANDITHAR HOSPITAL
Eligibility
Inclusion criteria
Inclusion criteria: BLOOD SUGAR FASTING >126 mg/dl and >200,post prandial blood sugar >200 and 7% AND < 11%,DIABETES PERIPHERAL NEUROPATHY MADHUMEGA AVATHAIGAL,PATIENT WHO IS ALREADY UNDER SIDDHA MEDICATION FOR MADHUMEGAM,DIABETES WITH HYPERTENSION.
Exclusion criteria
Exclusion criteria: AGE BETWEEN 30 YEARS TO 65 YEARS BOTH GENDER,GLYCATED HAEMOGLOBIN 11%, INSULIN DEPENDENT DIABETES MELLITUS,SECONTARY DIABETES MELLITUS,PREGNANT WOMEN AND PLANNING TO BE PREGNANT WITHIN 3 MONTHS,GESTATIONAL DIABETES,EXISTING RENAL FAILURE INDICATED BY ELEVATED SERUM CREATININE LEVELS,CNS DISORDER CORONARY ARTERY DISEASE,THYROID DYSFUNCTION ,MALIGNANT AND ACCELERATED HYPERTENSIVE,SUBJECT THOSE WHO ARE NOT WILLING TO GIVING INFORMED CONCENT.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| PRIMARY OUTCOME IS ASSESSED BY COMPARING THE BLOOD SUGAR HbA1C LEVEL AND DIABETIC PERIPHERAL NEUROPATHY SCALE BOTH GROUPS BEFORE AND AFTER TREATMENT ASSESMENTTimepoint: 90 DAYS | — |
Secondary
| Measure | Time frame |
|---|---|
| SECONDARY OUTCOME WILL BE ASSESSED BY COMPARING THE FOLLOWING THREE PARAMETERS PRE AND POST TREATMENT CHANGES IN SIDDHA CLINICAL PARAMETERS.EVALUATING CLINICAL LAB PARAMETERS.Timepoint: 90 DAYS | — |
Countries
India
Contacts
Public ContactDR SATHESH KUMAR M K
NATIONAL INSTITUTE OF SIDDHA
Outcome results
None listed